A model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-0509
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen ; volume:6 ; number:1 ; day:8 ; month:11 ; year:2012 ; pages:1-22 ; date:12.2012
BMC systems biology ; 6, Heft 1 (8.11.2012), 1-22, 12.2012
- Urheber
-
Lebedeva, Galina
- Beteiligte Personen und Organisationen
-
Yamaguchi, Azusa
Langdon, Simon P.
Macleod, Kenneth
Harrison, David J.
SpringerLink (Online service)
- DOI
-
10.1186/1752-0509-6-138
- URN
-
urn:nbn:de:1111-2016072961023
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lebedeva, Galina
- Yamaguchi, Azusa
- Langdon, Simon P.
- Macleod, Kenneth
- Harrison, David J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity
Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity
iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Tamoxifen
Prenylation inhibitors stimulate both estrogen receptor α transcriptional activity through AF-1 and AF-2 and estrogen receptor β transcriptional activity
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Synthesis of Tamoxifen‐Artemisinin and Estrogen‐Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer
The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer
Mechanistic analysis of enhancer sequences in the estrogen receptor transcriptional program
Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity
Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity
iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Tamoxifen
Prenylation inhibitors stimulate both estrogen receptor α transcriptional activity through AF-1 and AF-2 and estrogen receptor β transcriptional activity
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Synthesis of Tamoxifen‐Artemisinin and Estrogen‐Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer
The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer
Mechanistic analysis of enhancer sequences in the estrogen receptor transcriptional program
Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity
Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity
iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Tamoxifen
Prenylation inhibitors stimulate both estrogen receptor α transcriptional activity through AF-1 and AF-2 and estrogen receptor β transcriptional activity
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Synthesis of Tamoxifen‐Artemisinin and Estrogen‐Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer
The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer